通过人群基因组筛查项目发现的RET致病性变异患者的甲状腺切除术结局
这项回顾性横断面研究纳入2016年6月1日至2022年5月31日期间通过人群基因组筛查项目发现携带RET致病性/可能致病性(P/LP)变异并接受甲状腺切除术的75例患者,其中20例(27%)接受全甲状腺切除术,13例(65%)同时行中央颈淋巴结清扫。术后病理显示12例甲状腺髓样癌(MTC)和2例甲状腺乳头状癌,所有恶性肿瘤均为临床隐匿性,术后监测未发现顽固性疾病证据。
要点
- 75例通过人群基因组筛查发现RET P/LP变异的患者中,20例(27%)接受了全甲状腺切除术。
- 20例手术患者中13例(65%)行中央颈淋巴结清扫,术前均无临床明显疾病。
- 术后病理确诊12例MTC(10例I期、1例II期、1例III期、无IV期)和2例甲状腺乳头状癌。
核心结论
- 在这项横断面研究中,手术病理发现的所有恶性肿瘤均为临床隐匿性,手术干预仅基于人群基因组筛查发现的P/LP RET变异。
- 作者认为基因组筛查可能为MTC的早期发现和治疗提供机会,并有可能改善患者结局。
研究设计与样本
- 回顾性横断面研究,纳入2016年6月1日至2022年5月31日期间在一家农村三级医疗中心通过人群基因组筛查项目发现P/LP RET变异并接受甲状腺切除术的患者,平均随访22.4个月(范围2-76个月)。
- 共75例患者通过基因组筛查发现P/LP RET变异,其中20例(27%;11例女性[55%]、9例男性[45%];中位年龄48岁[范围22-73岁])接受全甲状腺切除术。
主要发现
- 20例手术患者中13例(65%)同时行中央颈淋巴结清扫,手术时均无临床明显疾病。
- 术后病理显示12例为MTC,2例为甲状腺乳头状癌;MTC患者中10例为I期、1例为II期、1例为III期,无IV期。
- 基于术后监测影像和实验室结果,无患者有顽固性疾病证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Population-based genomic screening can facilitate early detection of medullary thyroid carcinoma (MTC) in patients with pathogenic/likely pathogenic (P/LP) RET variants. OBJECTIVE: To evaluate the clinical treatment and patient outcomes after identification of P/LP RET proto-oncogene variants associated with the risk of MTC via a population genomic screening program. DESIGN, SETTING, PARTICIPANTS: This retrospective cross-sectional study was completed between June 1, 2016, and May 31, 2022, for a mean follow-up period of 22.4 months (range, 2-76 months). The study included patients who were identified as having P/LP RET variants through a population genomic screening program at a rural tertiary care center and who underwent thyroidectomy after results disclosure. MAIN OUTCOMES AND MEASURES: The outcomes of interest were preoperative evaluation and treatment-related outcomes. Measures included imaging and laboratory findings, extent of surgery, pathologic diagnosis, and staging. RESULTS: Seventy-five patients were identified as having P/LP RET variants exclusively through genomic screening. Twenty of these patients (27%; 11 women [55%] and 9 men [45%]; median age, 48 years [range, 22-73 years]) underwent total thyroidectomy; 13 of these patients (65%) also had a central neck dissection. No patients had clinically apparent disease at the time of surgery. Pathologic findings indicated MTC for 12 patients and papillary thyroid carcinoma in 2. Of patients with MTC, 10 had stage I disease, 1 had stage II disease, 1 had stage III disease, and none had stage IV disease. Based on postoperative surveillance imaging and laboratory results, no patient had evidence of recalcitrant disease. CONCLUSIONS AND RELEVANCE: In this cross-sectional study, all malignant neoplasms identified on surgical pathology were clinically occult, with surgical intervention based solely on the identification of the P/LP RET variant via population genomic screening. This finding suggests that genomic screening may provide opportunities for early detection and treatment of MTC, with the potential for improved patient outcomes.
引用
- Pichardo PFA, Hellums RN, Hao J, et al. Thyroidectomy Outcomes in Patients Identified With RET Pathogenic Variants Through a Population Genomic Screening Program. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36602781. doi:10.1001/jamaoto.2022.4195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。